These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23147779)

  • 1. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
    Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
    Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition.
    Chen W; Lou H; Zhang H; Nie X; Lan W; Yang Y; Xiang Y; Qi J; Lei H; Tang H; Chen F; Deng F
    Sci China Life Sci; 2011 Jul; 54(7):606-16. PubMed ID: 21748584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
    Chen J; Huang SL; Li T; Chen XL
    Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.
    Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED
    Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
    Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
    Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
    Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
    AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours.
    Porto L; Kieslich M; Franz K; Lehrnbecher T; Zanella F; Pilatus U; Hattingen E
    Eur J Paediatr Neurol; 2011 May; 15(3):214-21. PubMed ID: 21145271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
    Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
    Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
    J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Jenkinson MD; Smith TS; Joyce K; Fildes D; du Plessis DG; Warnke PC; Walker C
    Neurology; 2005 Jun; 64(12):2085-9. PubMed ID: 15985578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopy shows improved performance to segregate high-grade astrocytoma subgroups when defined with the new 2021 World Health Organization classification of central nervous system tumors.
    Majós C; Pons-Escoda A; Naval P; Güell A; Lucas A; Vidal N; Cos M; Bruna J
    Eur Radiol; 2024 Apr; 34(4):2174-2182. PubMed ID: 37740778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
    Morales H; Kwock L; Castillo M
    J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
    J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
    Cheng LL; Chang IW; Louis DN; Gonzalez RG
    Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.